Literature DB >> 14736798

HLA typing is not predictive of proliferative diabetic retinopathy in patients with younger onset type 2 diabetes mellitus.

T Mimura, S Amano, S Kato, M Araie, H Funatsu, S Kitano, E Shimizu, H Noma, O Yoshino, S Hori.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14736798      PMCID： PMC1772013          DOI： 10.1136/bjo.2003.023945

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  10 in total

1.  [Macrophages and HLA-DR expression in proliferative vitreoretinopathy].

Authors:  O F Scheiffarth; S Tang; A Kampik
Journal:  Fortschr Ophthalmol       Date:  1990

2.  HLA-DQB1*0201/0302 is associated with severe retinopathy in patients with IDDM.

Authors:  D Agardh; L K Gaur; E Agardh; M Landin-Olsson; C D Agardh; A Lernmark
Journal:  Diabetologia       Date:  1996-11       Impact factor: 10.122

3.  HL-A antigens and diabetes mellitus.

Authors:  J Nerup; P Platz; O O Andersen; M Christy; J Lyngsoe; J E Poulsen; L P Ryder; L S Nielsen; M Thomsen; A Svejgaard
Journal:  Lancet       Date:  1974-10-12       Impact factor: 79.321

Review 4.  Diabetes mellitus. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1985

5.  Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.

Authors:  V Horton; I Stratton; G F Bottazzo; M Shattock; I Mackay; P Zimmet; S Manley; R Holman; R Turner
Journal:  Diabetologia       Date:  1999-05       Impact factor: 10.122

6.  Genetic marker associations with proliferative retinopathy in persons diagnosed with diabetes before 30 yr of age.

Authors:  K J Cruickshanks; C M Vadheim; S E Moss; M P Roth; W J Riley; N K Maclaren; D Langfield; R S Sparkes; R Klein; J I Rotter
Journal:  Diabetes       Date:  1992-07       Impact factor: 9.461

7.  [Risk factors for occurrence and progression of diabetic retinopathy].

Authors:  H Funatsu; S Hori; Y Ohashi; T Ishigaki
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1993-08

8.  HLA-associated susceptibility to type 2 (non-insulin-dependent) diabetes mellitus: the Wadena City Health Study.

Authors:  S S Rich; L R French; J M Sprafka; J P Clements; F C Goetz
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

9.  Relationship between human leukocyte antigen status and proliferative diabetic retinopathy in patients with younger-onset type 1 diabetes mellitus.

Authors:  Tatsuya Mimura; Hideharu Funatsu; Yasuko Uchigata; Shigehiko Kitano; Hidetaka Noma; Erika Shimizu; Yasuhiro Konno; Shiro Amano; Makoto Araie; Osamu Yoshino; Yasuhiko Iwamoto; Sadao Hori
Journal:  Am J Ophthalmol       Date:  2003-06       Impact factor: 5.258

10.  Genetic susceptibility to non-insulin dependent diabetes mellitus and glucose intolerance are located in HLA region.

Authors:  E Tuomilehto-Wolf; J Tuomilehto; G A Hitman; A Nissinen; J Stengård; J Pekkanen; P Kivinen; E Kaarsalo; M J Karvonen
Journal:  BMJ       Date:  1993-07-17
  10 in total
  2 in total

Review 1.  [Human leukocyte antigen (HLA) system in ophthalmology].

Authors:  T Lapp; D Reinhold; D Böhringer; T Reinhard
Journal:  Ophthalmologe       Date:  2013-09       Impact factor: 1.059

2.  HLA genes, islet autoantibodies and residual C-peptide at the clinical onset of type 1 diabetes mellitus and the risk of retinopathy 15 years later.

Authors:  Richard A Jensen; Elisabet Agardh; Ake Lernmark; Soffia Gudbjörnsdottir; Nicholas L Smith; David S Siscovick; Carina Törn
Journal:  PLoS One       Date:  2011-03-11       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.